All Stories

  1. Rituximab biosimilars for lymphoma in Europe

    Article • Expert Opinion on Biological Therapy, September 2019, Taylor & Francis

    Wojciech Jurczak

  2. Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up

    Article • Leukemia & Lymphoma, April 2019, Taylor & Francis

    Wojciech Jurczak

  3. Avatrombopag for the treatment of immune thrombocytopenia

    Article • Expert Review of Clinical Immunology, March 2019, Taylor & Francis

    Wojciech Jurczak

  4. Relapsing/ refractory DLBCL therapy New drugs in DLBCL

    Article • Future Oncology, October 2018, Future Medicine

    Wojciech Jurczak